Literature DB >> 14667562

Smoking, gender and rheumatoid arthritis-epidemiological clues to etiology. Results from the behavioral risk factor surveillance system.

Eswar Krishnan1.   

Abstract

OBJECTIVES: This study was undertaken to confirm and extend our earlier observation that gender is a biological effect modifier of smoking-rheumatoid arthritis (RA) relationship in a diverse national survey sample in the United States.
METHODS: Smoking history of 644 cases of RA and 1509 geographically matched general population controls were compared using weighted logistic regression.
RESULTS: There were 644 respondents with RA (cases) and 1509 geographically matched controls. Cases were significantly younger, less educated, more likely to be single and female than controls. Among cases 57% were smokers while among controls 49% smoked. Among women, after adjusting for age, hysterectomy had an age adjusted odds ratio 1.45, (95% CI 0.99-2.10) and menopause an adjusted odds ratio 1.18 (95% CI 0.99-2.10) were associated with smoking. In univariable analysis ever-smoking was associated with increased risk of RA (odds ratio 1.34, 95% CI 1.0-1.81). Among the strata of smokers, there was an increasing gradient of risk with increasing exposure to smoking (P = 0.041). In separate multivariable models, smoking increased the risk in men (odds ratio 2.29, 95% CI 1.35-3.90) while in women the risk was not elevated (odds ratio 0.98, 95% CI 0.67-1.42). After adjusting for the statistically significant interaction both female gender (odds ratio 2.30, 95% CI 1.39-3.83) and having ever smoked (odds ratio 2.31, 95% CI 1.36-3.94) emerged as significant risk factors for RA.
CONCLUSIONS: Gender interacts with smoking in by an unknown mechanism to lead to differential risk of RA.

Entities:  

Mesh:

Year:  2003        PMID: 14667562     DOI: 10.1016/s1297-319x(03)00141-6

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  8 in total

1.  Rheumatoid arthritis in Burkina Faso: clinical and serological profiles.

Authors:  Dieu-Donné Ouédraogo; Joseph Singbo; Ousséini Diallo; Serge Aimé Sawadogo; Hervé Tiéno; Youssouf Joseph Drabo
Journal:  Clin Rheumatol       Date:  2011-09-02       Impact factor: 2.980

2.  Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

Authors:  S P Linn-Rasker; A H M van der Helm-van Mil; F A van Gaalen; M Kloppenburg; R R P de Vries; S le Cessie; F C Breedveld; R E M Toes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

3.  The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.

Authors:  Ct Chou; Ht Liao; Ch Chen; Ws Chen; Hp Wang; Ky Su
Journal:  Biomark Insights       Date:  2007-05-03

4.  Pro-inflammatory activity in rats of thiocyanate, a metabolite of the hydrocyanic acid inhaled from tobacco smoke.

Authors:  Michael Wellesley Whitehouse; Mark Jones
Journal:  Inflamm Res       Date:  2009-04-10       Impact factor: 4.575

5.  Risk factor assessment of rheumatoid arthritis in North Kerala.

Authors:  Binoy Paul; Rosh Pariyapurath
Journal:  Eur J Rheumatol       Date:  2018-08-07

6.  Modifiable risk factors for RA: prevention, better than cure?

Authors:  Manjari Lahiri; Catharine Morgan; Deborah P M Symmons; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2011-11-24       Impact factor: 7.580

7.  Lifestyle factors associated with incidence of rheumatoid arthritis in US adults: analysis of National Health and Nutrition Examination Survey database and meta-analysis.

Authors:  Ding Ye; Yingying Mao; Yang Xu; Xueli Xu; Zhijun Xie; Chengping Wen
Journal:  BMJ Open       Date:  2021-01-26       Impact factor: 2.692

Review 8.  The Autoimmune Ecology.

Authors:  Juan-Manuel Anaya; Carolina Ramirez-Santana; Maria A Alzate; Nicolas Molano-Gonzalez; Adriana Rojas-Villarraga
Journal:  Front Immunol       Date:  2016-04-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.